Beneski Benjamin Machinas
SEC CIK 2057918 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | SVP, Chief Technical Off | 195.3K | — | $62.5K | 7 | 2025-03-01 | 2026-03-31 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 16:47 | 2026-03-31 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $2.50 | -2,867 | 195.3K | -1% | -$7,168 | |
| 2026-03-18 | 2026-03-16 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $2.47 | -4,835 | 198.2K | -2% | -$11.9K | |
| 2026-03-04 | 2026-03-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $2.60 | -7,132 | 203.0K | -3% | -$18.5K | |
| D | 2026-02-04 | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $1.73 | -7,549 | 210.2K | -3% | -$13.1K |
| 2025-11-19 | 2025-11-17 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $1.22 | -786 | 217.7K | -0.4% | -$958.92 | |
| 2025-03-18 | 2025-03-14 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | S - Sale | $1.98 | -5,488 | 218.5K | -2% | -$10.9K | |
| D | 2025-03-05 | 2025-03-01 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Off | A - Grant | $0.00 | +31.8K | 224.0K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations